DNTH news

Latest 1 stories · newest Jun 12, 2026

DNTH

Dianthus Therapeutics presents autoimmune pipeline advances in June 2026 update

Dianthus Therapeutics released an investor presentation highlighting its autoimmune-focused pipeline, featuring two lead candidates: claseprubart and DNTH212, both in clinical development. The company outlined clinical trial plans and market opportunities for complement therapies, though both compou…

Other Jun 12, 2026 sentiment +0.20 SEC filing ↗

BriefTape provides AI-summarized public SEC filings for informational purposes only. Content does not constitute investment advice. Always verify against source filings at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.

The same DNTH feed as JSON for your bot or app:

GET https://api.brieftape.com/v1/tickers/DNTH/newsSTART FREE